The May Consumer Price Index report, released early Wednesday, revealed more than just a hotter headline number—inflation is spreading across a wider range of categories. Data highlighted by SoFi ...
The S&P 500 recorded its ninth straight daily gain on Tuesday. The S&P 500's latest string of records has come with a catch: Fewer stocks are participating in the rally. That could leave the large-cap ...
The S&P 500’s latest string of records has come with a catch: Fewer stocks are participating in the rally. That could leave the large-cap benchmark index vulnerable if momentum in its biggest leaders, ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Erik Steiger discusses the operational pain ...
The equity risk premium has effectively vanished. While it is a signal worth heeding, it is not cause for immediate alarm, particularly for portfolios that are genuinely diversified. In recent weeks ...
Wall Street is chasing AI momentum and leaving much of the market in the dust, but the smaller stocks are keeping up. The Invesco S&P 500 Equal Weight ETF, which counts every S&P 500 stock as if they ...
Opening moments of games can often feel long and slow, and may even be boring as the game must teach you how to play it first thing. They’re a necessary evil, but there's a new high bar, as the new ...
BFS Investments receives a Below Average Parent rating. The Parent Pillar assessment is based on a structured evaluation of key factors that influence a firm's ability to support strong investment ...
Gregory Daco, EY-Parthenon chief economist, joins 'Squawk Box' to discuss the state of the economy, impact of the Middle East conflict, impact of AI, the Fed's interest rate outlook, and more. Got a ...
The S&P 500 and Nasdaq each set intraday records on Friday, but a majority of stocks were actually falling. The S&P 500 was up 0.7% after setting an intraday record at 7164.45. The Nasdaq was up 1.5% ...
Builders FirstSource CEO Peter Jackson said the company is positioning itself as a full-service partner for homebuilders through acquisitions, installation services, and the myBLDR digital portal. BFS ...
(RTTNews) - Kymera Therapeutics, Inc. (KYMR) announced that the first patient has been dosed in its BREADTH Phase 2b clinical trial evaluating KT-621, an oral, highly selective degrader of STAT6, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results